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Abstract 
The use of amphipathic pH-responsive polymers to transport sugars across cell membranes 
has been shown to improve the cryopreservation of mammalian cells. However, the effect of 
these polymers on cell viability and morphology has not yet been thoroughly analysed. In 
this study, the objective was to investigate the functional and structural effects of an 
amphipathic polymer, PP-50, upon an osteosarcoma cell line (SAOS-2). Cellular growth 
curves confirmed similar doubling times in PP-50 treated cells and untreated cells. PP-50 
concentrations (10-2000 µg/ml) were well tolerated by cells after 2, 24 and 48 hours of 
incubation, as measured by mitochondrial enzyme activity and lactate dehydrogenase 
release. Analysis by flow cytometry demonstrated that PP-50 did not induce any additional 
apoptosis or necrosis in polymer treated cells compared to untreated cells. Phase contrast, 
confocal and transmission electron microscopy analysis of PP-50 treated cells revealed no 
signs of morphological changes, with cells maintaining their nucleus size and membrane 
integrity after treatment. PP-50 was shown to have no negative cellular effects, which is a 
critical characteristic of polymers towards use in cryopreservation and biomedical 
applications. In addition, the methodology and protocols established in this work provided a 
robust and comprehensive analysis of PP-50’s cellular effects, thus making them well suited 
for determining these effects in mammalian cells exposed to other polymers intended for 
biological applications. 
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1. Introduction
The ability of biopolymers to act as carrier systems makes them attractive for biological 
applications [1,2]. Biopolymers are able to transport a variety of molecules, such as 
successful cancer therapy candidates and proteins, across mammalian cell membranes, 
acting as permeabilising agents and improving the pharmacological and therapeutic 
properties of drugs [3,4]. The role of biopolymers in the advancement of drug delivery 
systems (DDS) has been well documented, with polymers providing controlled release of 
therapeutic agents over long periods, cyclic dosage, and adjustable release of both 
hydrophilic and hydrophobic drugs [5,6]. However, little attention has been given in the 
literature to the effect of biopolymer delivery systems on cell physiology [4,7]. 
In addition to their role as DDS, polymers have been shown to be effective in the 
cryopreservation of mammalian cells [8,9]. Currently, cryopreservation of cell lines is a 
technically demanding process leading to recurrent failures related to poor revival rates and 
atypical cell properties. Cryopreservation techniques must be improved to overcome 
difficulties in the transportation and prolonged storage of mammalian and stem cells, as 
these issues have hindered their use in clinical studies and industrial applications [10–12]. 
To survive long-term storage at low temperatures, cells typically require cryoprotective 
agents (CPAs), such as dimethyl sulfoxide (Me2SO) or glycerol [13–15]. However, 
successful cryopreservation of mammalian cells requires high concentrations of CPAs and 
their toxicity has been recognised as a critical barrier to further advancement of the field 
[13,16]. 
Sugars are key non-toxic components in a large number of cryopreservation protocols. They 
help in the dehydration of cells by increasing osmolarity, in addition to preserving structural 
integrity. They also function as an osmotic buffer, reducing osmotic shock by decreasing the 
rate and amount of cell swelling [17,18]. However, sugar transport across animal cell 
membranes is restricted to monosaccharides since disaccharides do not readily diffuse 
across the plasma membrane [19]. This is a major challenge when high concentrations of 
disaccharides such as trehalose are needed within cells for viable cryopreservation [13,20].  
To overcome this obstacle, different approaches have been developed to increase the levels 
of intracellular disaccharides, such as the use of ATP receptor channels or engineered 
membrane pores [20–22]. Disadvantages of these alternatives include the induction of cell 
death by either necrosis or apoptosis, amongst others [23]. 
One effective method to induce disaccharide transport into cells involves the use of 
amphipathic biodegradable pH-responsive polymers due to their ability to permeate cell 
membranes [9,24]. These polymers have been developed to mimic the membrane 
permeabilising activity of viral and bacterial peptides [25]. Typically, they undergo a 
conformational change from extended charged chains to aggregated hydrophobic structures 
as the environmental pH drops below their pKa, thus interacting with the hydrophobic interior 
of phospholipid bilayers. This facilitates increased membrane permeability by pore formation 
or by increasing membrane solubilisation [26,27].  
Recently, research focused on the cryopreservation of human red blood cells and 
osteosarcoma cells has shown an increase in phospholipid bilayer permeability to trehalose 
when using the biopolymer PP-50, a polymer consisting of poly(L-lysine iso-phthalamide) 
grafted with the hydrophobic amino acid L-phenylalanine. This has successfully led to an 
increase in post-thaw viabilities of cryopreserved mammalian cells [8,28].  
Despite its successful use in cryopreservation, the effect of PP-50 on cell viability, 
membrane integrity and cell morphology has not been studied in depth in previous works. In 
this study, the effect of PP-50 on these characteristics was evaluated in osteosarcoma cells, 
a model for adherent cells, to provide key information regarding this amphipathic biopolymer 
towards use in cryopreservation and other clinical applications. In addition, the methodology 
and protocols established in this work provided a robust and comprehensive analysis of PP-
50’s cellular effects, thus making them well suited for determining these effects in 
mammalian cells exposed to other polymers intended for biological applications. 
2. Materials and methods
2.1. Materials 
The SAOS-2 cells were obtained from the European Collection of Cell Cultures. Dulbecco’s 
modified Eagle’s medium (DMEM), foetal bovine serum (FBS), L-glutamine, penicillin, 
streptomycin and trypan blue were purchased from Invitrogen (UK). Phosphate-Buffered 
Saline (PBS) and trypsin–EDTA were purchased from Life Technologies™ (UK). The 
CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) was obtained from 
Promega (UK). The Annexin V-FITC Apoptosis Detection Kit was obtained from BD 
Biosciences (UK). The Lactate Dehydrogenase (LDH) Activity Assay Kit, calcein, propidium 
iodide (PI) and Hoechst H33342 were obtained from Sigma-Aldrich (UK). All chemicals and 
biochemicals used were of analytical grade.  
2.2. PP-50 synthesis and characterisation 
The synthesis and characterisation of the PP-50 polymer were as previously described by 
Lynch et al. [28]. PP-50 consists of a poly(L-lysine iso-phthalamide) backbone grafted with L-
phenylalanine at a degree of grafting of 46.2% (Mn = 23.0 kDa) 
2.3. Cell culture 
SAOS-2 osteosarcoma cells were cultured in DMEM with FBS (10% v/v), L-glutamine (2 
mM), penicillin (100 IU/ml), and streptomycin (100 µg/ml) in 75 cm2 flasks supplied by 
Corning (UK). Cells were incubated in a 37°C incubator with 5% of CO2. At 70% confluence, 
cells were washed twice with PBS, then subcultured with trypsin (0.05% w/v) and EDTA 
(0.02% w/v) and subsequently replated for further expansion or cytotoxicity studies.  
2.4. Cellular growth curves 
Cells were passaged into 12-well plates (0.2 x 106 cell/well) and grown for 24 hrs. Cells were 
then incubated with PP-50 (25 and 250 µg/ml) for 120 hrs. Control cells were incubated in 
growth media without PP-50. Cell density and viability were determined every 24 hrs by the 
trypan blue (TB) exclusion method using a cell counter [29]. Cells negative for TB were 
considered live and those stained blue were considered dead. The doubling times (td) were 
calculated using Eq. (1), where t1 and t2 represent the time at time-points 1 and 2, 
respectively, and N(t1) and N(t2) represent the number of cells at time-points 1 and 2, 
respectively. 
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2.5. Cytotoxicity tests 
The cytotoxicity of the polymer PP-50 was evaluated using colorimetric MTS and LDH tests. 
A range of concentrations between 10 and 2,000 µg/ml of PP-50 were tested after 2, 24 and 
48 hour incubations. Different incubation times were used to assess cell viability by 
measuring cell growth in the presence of PP-50 [20,30]. 
2.5.1. MTS test 
Cells were passaged into 96-well plates (5 x 103 cells/well) and grown for 24 hours. Cells 
were then washed with PBS and incubated with PP-50 (10 to 2,000 µg/ml) for 2, 24 and 48 
hours. Viable cells were determined using the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay according to the manufacturer’s instructions. Absorbance was measured 
at 490 nm using a 96-well plate reader (BMG Labtech, UK) and corrected by subtraction of 
background absorbance. 
2.5.2. LDH test 
Cells were passaged into 96-well plates (5 x 103 cells/well) and grown for 24 hours. After 2, 
24 and 48 hours of incubation with PP-50, 50 µl of the cell growth media were removed from 
each sample and assayed for lactate dehydrogenase using the Lactate Dehydrogenase 
Activity Assay Kit, according to the manufacturer’s instructions. Media from lysis buffer 
(Triton-X 0.2% v/v) were used to determine maximal release values. Absorbance was 
measured at 450 nm using a 96-well plate reader and corrected by subtraction of 
background absorbance. 
2.6. Apoptosis assessment 
2.6.1. Flow cytometry 
For early apoptosis quantification, cells were incubated with 250 µg/ml of PP-50 and then 
analysed using the Annexin-V-FITC/propidium iodide Assay Kit according to the 
manufacturer’s instructions, using a FACScan flow cytometer (Becton Dickinson, USA). A 
staurosporine treatment (5 µM for 2 hours) was used as a positive control for apoptotic cells. 
Data were acquired using Cellquest software and analysed using the Beckman Coulter 
Summit software. 
2.7. Cell morphology 
2.7.1. Phase contrast microscopy 
Cells were passaged into 6 well plates (0.5 x 106 cells/well) and grown for 24 hours. After 
exposure to 250 µg/ml of PP-50 for 2 and 24 hours, cells were examined by a contrast light 
microscope. Control cells were incubated in growth media without PP-50. 
2.7.2. Confocal microscopy 
Cells were assessed using 2 mM calcein and 5 µg/ml propidium iodide (PI) stains in the 
absence and presence of the polymer. In addition, the permeable dye Hoechst 33342 (5 
µg/ml), was used to evaluate the nuclear morphology of cells. Cells were placed on 1.8 cm2 
chambered cell culture cover glasses (Nunc, UK) at a density of 5 x 104 cells/well and 
imaged using a TCS SP5 inverted laser scanning microscope (Leica, Germany) after 24 
hour incubation. A positive control for PI staining was prepared using fixation with 
paraformaldehyde solution (4% w/v) for 15 minutes. 
2.7.3. Transmission electron microscopy 
The cell morphology of SAOS-2 cells was evaluated using transmission electron microscopy. 
Cells were incubated in the absence and presence of PP-50 for 2 and 24 hours and then 
washed twice with saline buffer (0.155 M NaCl). Subsequently, cells were fixed in 4% 
glutaraldehyde in 0.1 M HEPES buffer at pH 7.4 for 12 hours at 4° C. They were rinsed in 
0.1 M HEPES buffer five times and then treated with 1% osmium ferricyanide at room 
temperature for 2 hours. Next, they were rinsed in deionised water five times and treated 
with 2% uranyl acetate in 0.05 M maleate buffer at pH 5.5 for 2 hours at room temperature. 
They were again rinsed in deionised water and dehydrated in an ascending series of ethanol 
solutions from 70% to 100%. This was followed by treatment with 2 changes of dry 
acetonitrile and infiltration with Quetol epoxy resin. Images were examined under a 
transmission electron microscope (Tecnai G2, FEI Company, USA) operated at 120 kV 
using an AMT XR60B digital camera running Deben software. 
2.8 Statistical analysis 
All measurements were carried out by triplicate in three different replicates. The flow 
cytometry results were analysed using a one-way ANOVA followed by a Tukey’s test for 
multiple comparisons. The tests were analysed using GraphPad Prism (GraphPad Software, 
US). The difference was considered statistically significant when p < 0.05. 
3. Results
3.1 Cellular growth curves 
Cell growth in the presence of PP-50 was measured using the trypan blue exclusion method 
over 120 hrs (Fig. 1). As seen in Fig. 1, cell density increased in an exponential fashion for 
the control and cells treated with 25 µg/ml of PP-50. Cells treated with 250 µg/ml of PP-50 
showed a decrease in cell density when compared to control. The doubling times were 27.7 
± 1.58 hrs, 28 ± 1.76 hrs and 32 ± 0.16 hrs for the control, 25 µg/ml and 250 µg/ml of PP50, 
respectively. Cell viabilities in all conditions tested remained higher than 90% during the 
entire incubation period. 
3.2 Cytotoxicity of PP-50 
3.2.1. Metabolic activity 
The effect on metabolic activity of cells incubated with PP-50 was investigated using the 
MTS assay (Fig. 2). The cytotoxicity was examined as a function of the polymer 
concentration and incubation time. PP-50 concentrations ranging from 10 to 2,000 µg/ml 
were not cytotoxic and were well tolerated by the cells after 2, 24 and 48 hour incubations. 
PP-50 only showed a marginal decrease in metabolic activity at 1,500 and 2,000 µg/ml after 
48 hours of incubation.  
3.2.2. LDH assay 
The effect on membrane integrity in osteosarcoma cells was studied using the LDH assay 
(Fig. 3). Media samples from cells treated with PP-50 for 2, 24 and 48 hours were assayed 
for lactate dehydrogenase. As seen in Fig. 3, PP-50 did not increase the release of LDH into 
the media of PP-50 treated cells compared to the untreated control. Reduced LDH release 
was observed in the entire range of PP-50 concentrations, with levels of less than 20% at 
concentrations up to 2,000 µg/ml of PP-50, similar to the untreated cells. 
3.3. Assessment of apoptosis 
3.3.1. Flow cytometry 
The induction of apoptosis was assessed by incubating cells with 250 µg/ml of PP-50 for 2 
and 24 hours (Fig. 4). Apoptosis and necrosis were observed using the Annexin V-FITC/PI 
Kit. As shown in Fig. 4, there was a significant decrease (p<0.05) in apoptotic cells after 2 
and 24 hours of incubation with PP-50 when compared to untreated cells. The percentage of 
apoptotic cells after 2 and 24 hours of incubation in the control group was 20% ± 1.4% and 
13% ± 0.5%, respectively, whereas cells treated with PP-50 had apoptotic percentages of 
10% ± 0.4% and 9% ± 0.5, respectively. Polymer treated cells after 2 and 24 hours of 
incubation also showed a significant decrease (p<0.05) of 64% and 67%, respectively, in 
apoptotic cells when compared to cells treated with staurosporine. 
In addition, there was also a significant decrease (p<0.05) in necrotic cells in PP-50 treated 
cells after 24 hours of incubation when compared to the control. The percentage of necrotic 
cells after 24 hours of incubation in the control group was 5% ± 0.4%, whereas cells treated 
with PP-50 had a necrotic percentage of 2% ± 0.13%. 
3.4. Cell Morphology 
3.4.1. Phase contrast microscopy 
After exposure to 250 µg/ml of PP-50 for 2 and 24 hours, cell morphology was examined by 
phase contrast microscopy (Fig. 5). Clearly visible cytoskeletons were observed in both 
control and PP-50 treated cells, with the majority of cells attached to the surface. There was 
a marginal detachment of cells from the well in PP-50 treated cells. Additionally, control and 
PP-50 treated cells showed normal morphology when compared to staurosporine treated 
cells, a well-known apoptosis inducer.  
3.4.2. Confocal microscopy 
The cell morphology after incubation with 200 µg/ml of PP-50 for 24 hours was also 
evaluated by calcein, propidium iodide and Hoechst 33342 fluorescence assay using 
confocal microscopy (Fig. 6). As shown in Fig. 6, there was no staining with propidium iodide 
either for untreated or PP-50 treated cells. Cells incubated in the presence of PP-50 also 
displayed normal nuclei features, shown by the staining with Hoechst H33342. Calcein 
staining was seen only in the membrane of control cells, whereas in PP-50 treated cells, the 
staining was stronger and seen inside the cells. Similar results were also obtained for 2 
hours of incubation with PP-50 (data not shown). 
3.4.3. Transmission electron microscopy 
Transmission electron microscopy was utilised to further investigate morphological changes 
in cells incubated with PP-50 (Fig. 7). The ultrastructural features in SAOS-2 cells revealed 
regular nuclear membrane, intact nucleoli, homogeneous chromatin, and visible microvilli in 
both control and PP-50 treated cells. No morphological signs of apoptosis were observed 
either in the control or PP-50 treated cells. 
 
4. Discussion 
 
Previous studies have reported different methodologies to assess polymer cytotoxicity in 
mammalian cells [4,7]. However, a comprehensive study was needed to accurately 
determine cell viability, i.e., the parallel investigation of cell growth, metabolic activity, 
membrane integrity, and cell morphology. 
 
In this study, the cellular effect of PP-50 was tested in SAOS-2 cells. Analysis by trypan blue 
exclusion, MTS, LDH, and Annexin V-FITC/PI assays, as well as phase contrast, 
transmission electron and confocal microscopy, all showed that incubations with PP-50 did 
not increase cell cytotoxicity when compared to controls at the concentrations tested. 
 
Cell growth in the presence of PP-50 was studied using the trypan blue exclusion method 
(Fig. 1). Similar growth curves and viabilities were obtained with control cells and with cells 
treated with 25 µg/ml of PP-50. Although cell density was affected when incubating with 250 
µg/ml of PP-50, doubling time was not altered significantly (a 15% increase compared to 
control). This reduction in cell density can be explained partially by (1) cell detachment 
occurring at higher concentrations of PP-50 after long incubations and (2) the subsequent 
loss of cells in the washing steps prior to cell counting. Hence, detached cells are not taken 
into account for the calculation of cell density. However, PP-50 is typically used for biological 
applications in much lower concentrations with shorter incubation times. Previous studies 
have proven PP-50 to have a permeabilising effect on cell membranes when incubated at a 
low concentration of 25 µg/ml for less than 24 hours [8,28].  
 
Another factor possibly involved in this decrease in cell viability is the use of the trypan blue 
staining method. Despite the fact that it is widely used for measuring cell density, this 
method has several inherent disadvantages. It has been described in numerous studies as 
highly subjective and possessing significant accuracy errors [29,31].  
 
Metabolic activity of SAOS-2 cells was investigated using the MTS assay, a colorimetric 
method that measures the activity of cell cytoplasmic esterases (Fig. 2). PP-50 
concentrations ranging from 10 to 2000 µg/ml showed no toxic effect and no significant 
decrease in metabolic activity compared to untreated cells. These results are in agreement 
with previous studies [8].  
Membrane integrity was evaluated using the LDH assay (Fig. 3). LDH is a soluble cytosolic 
enzyme that is released into the culture medium following the loss of membrane integrity. 
Therefore, LDH activity can be used to determine loss of plasma membrane integrity due to 
biochemical perturbations [32,33]. After treatment with PP-50, the cell membranes remained 
intact, as shown by low LDH values below 20%. Cell exposure to PP-50 with different 
incubation periods did not increase cytotoxicity compared to the control. Overall, neither the 
MTS nor LDH assays resulted in evidence of cytotoxicity.  
Concentrations of 200 and 250 µg/ml of PP-50 were chosen for apoptosis and morphological 
analysis. These concentrations were 10-fold higher than the one proven to improve 
cryosurvival, and were selected in order to ensure the visualisation of any morphological or 
apoptotic effects of PP-50 [8]. 
To investigate the induction of cellular apoptosis as a result of incubation with PP-50, cells 
treated with the polymer were evaluated with Annexin V-FITC/PI and then analysed by flow 
cytometry (Fig. 4). Annexin V is widely used in conjunction with PI to determine whether cells 
are viable, apoptotic, or necrotic through differences in plasma membrane integrity and 
permeability [34]. Apoptosis in PP-50 treated cells accounted for approximately 10% of the 
total population for both 2 and 24 hour incubations. When compared to untreated cells, PP-
50 treated cells had a reduction in apoptosis of 50% and 21%, respectively. PP-50 treated 
cells also showed a significant reduction in necrotic cells from the control. In addition, when 
compared to staurosporine, an apoptosis inducer, PP-50 showed a significant decrease in 
apoptotic cells thus supporting its biocompatibility. 
It was observed that after a 2 hour incubation, the percentage of apoptotic cells amongst 
untreated cells was higher than expected (around 20%). This may be explained by the use 
of trypsin, a protease with proteolytic activity, to detach the cells during the harvesting 
process, which may lead to false positives due to mechanical damage [35,36].  
To further investigate the effect of PP-50, changes in cell morphology and cell detachment 
from the wells were also used as indicators of viability (Fig. 5). Phase contrast microscopy 
showed standard cytoskeletons with a regular structure and only a marginal cell detachment 
in cells incubated with 250 µg/ml of PP-50 for both 2 and 24 hours. No morphological 
differences were seen in cells treated with PP-50 when compared to untreated cells.  
PP-50 treated cells were subsequently analysed using confocal microscopy. Propidium 
iodide, a non-permeable dye, was used to assess cell viability as it is not taken up by living 
cells [34,37]. Calcein, a non-permeable hydrophilic dye which accounts for the activity of 
cytoplasmic esterases, was used to both stain cells capable of incorporating it into their 
cytoplasm and to simultaneously assess any PP-50 transport of the dye into the cytoplasm 
[38,39]. As shown in Fig. 6, no propidium iodide positive cells were seen in incubations with 
PP-50, again demonstrating that PP-50 is not cytotoxic to cells. Cells incubated with PP-50 
displayed increased staining with calcein when compared to controls, hence demonstrating 
PP-50’s ability to permeabilise cell membranes with hydrophilic molecules, as previously 
shown [8,28].  
Transmission electron microscopy was used to investigate morphological changes in PP-50 
treated cells that could have been omitted by other methods (Fig. 7). However, no difference 
in either morphology or size of PP-50 treated cells was found when compared to untreated 
cells. This is in agreement with previous methods used in this study to assess the cellular 
effect of PP-50. 
In this work, PP-50 has been shown to have no cytotoxic effects on osteosarcoma cells, 
making it well suited for use in existing cell cryopreservation protocols and therapeutic 
applications. In addition, the complete set of protocols used to assess cell viability in the 
presence of PP-50 can also be used with different polymers in future studies. 
6. Conclusions
In this study, the cellular effect of an amphipathic pH-responsive biopolymer was studied. 
PP-50 concentrations ranging from 10 to 2,000 µg/ml were shown to have no negative effect 
on doubling time, metabolic activity and lactate dehydrogenase release in SAOS-2 cells. PP-
50 did not induce any additional apoptosis or necrosis in polymer treated cells compared to 
the control, highlighting a potential use in cell-based protocols for drug delivery. Incubation 
with PP-50 did not alter cell morphology in any way as shown by microscopy analysis, 
showing the safety of this polymer at the concentrations tested. Further work is needed to 
determine the effect of PP-50 in different cell systems, such as suspension cells or in vivo 
models. This study provides an important step toward the use of amphipathic biopolymers 
for cryopreservation and biomedical applications. 
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Figure captions 
Figure 1: Cellular growth curves (solid lines) and viabilities (dashed lines) of SAOS-2 cells in 
the absence or presence of PP-50. Measurements were determined by the trypan blue dye 
exclusion method. Data were derived from three replicates. Error bars represent the 
standard error. 
Figure 2: Metabolic activity of SAOS-2 cells after incubation for 2, 24 and 48 hours with 
various concentrations of PP-50. Data were normalised to cells incubated in the absence of 
PP-50 for the same incubation time. Data were derived from three replicates. Error bars 
represent standard error. 
Figure 3: Lactate dehydrogenase released by SAOS-2 cells after incubation for 2, 24 and 48 
hours with various concentrations of PP-50. Untreated cells were grown and analysed in the 
absence of PP-50. Data were derived from three replicates. Error bars represent standard 
error. 
Figure 4: Percentage of apoptotic and necrotic SAOS-2 cells after incubation with PP-50. 
Black bars represent apoptotic cells and grey bars represent necrotic cells. A) Incubation for 
2 hours with PP-50 (250 µg/ml). B) Incubation for 24 hours with PP-50 (250 µg/ml). 
Apoptosis and necrosis were determined by flow cytometry using Annexin V- FITC/PI. Cells 
positive only for Annexin V were considered to be apoptotic. Cells positive for both Annexin 
V and PI were considered to be necrotic. Data were derived from three replicates. Error bars 
represent standard errors. * denotes significant difference compared to untreated cells or as 
indicated in the figure (p < 0.05). 
Figure 5: Effect of PP-50 on SAOS-2 cell morphology as determined by phase contrast 
microscopy. A) Control cells incubated in the absence of PP-50. B) Cell incubation for 2 
hours with PP-50 (250 µg/ml). C) Cell incubation for 24 hours with PP-50 (250 µg/ml). D) 
Cell incubation with 5 µM of staurosporine for 4 hours. Morphological changes were 
examined and photographed using a phase contrast microscope. Data are representative of 
a minimum of three separate experiments. 
Figure 6: Confocal microscopy images of SAOS-2 cells fixed with 4% paraformaldehyde or 
incubated in the absence and presence of PP-50 (200 µg/ml) for 24 hours. Cells were first 
stained with 2 mM calcein (green fluorescence) and subsequently with 5 µg/ml propidium 
iodide (red fluorescence) and 5 µg/ml Hoechst H33342 (blue fluorescence). Data are 
representative of a minimum of three separate experiments. 
Figure 7: Effect of PP-50 on SAOS-2 cell morphology as determined by transmission 
electron microscopy. A) Control cells incubated in the absence of PP-50. B) Cell incubation 
for 2 hours with PP-50 (250 µg/ml). C) Cell incubation for 24 hours with PP-50 (250 µg/ml). 
Data are representative of a minimum of three separate experiments. Scale bars represent 2 
µm. 







